An experimental coronavirus vaccine from Oxford University appears to be effective at preventing COVID-19, according to findings from a small study in six monkeys.
British drugmaker AstraZeneca last month announced it had teamed up with researchers at the Oxford Vaccine Group and the Jenner Institute, which are developing the vaccine.
According to the report, some of the monkeys given a single shot of the vaccine developed antibodies against the virus within 14 days, and all developed protective antibodies within 28 days, before being exposed to high doses of the virus.
On May 13, clinical trials of the Chadox vaccine have started on humans as well. 1000 volunteers have participated in this trial. Many analysts have expressed happiness over the results of the vaccine and have said that the trial on humans is progressing at a fast pace.